Literature DB >> 3037777

The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein.

H Müller, R Nitschke.   

Abstract

The genome of infectious bursal disease virus (IBDV) consists of two segments of double-stranded (ds)RNA with molecular weights of 2.2 X 10(6) and 1.9 X 10(6) Da, respectively. After treatment of IBDV particles with proteinase K in the presence of sodium dodecyl sulfate (SDS), linear dsRNA molecules are released from the virus particles. However, after heating of virus particles at 100 degrees for 3 min in 1.5% SDS, without the protease, dsRNA-protein complexes can be seen under the electron microscope: Knob-like proteinaceous structures are linked to the ends of the dsRNA molecules of either size class which are circularized to form individual rings. A 90,000-Da IBDV structural polypeptide, the only protein encoded by the smaller genome segment, has been demonstrated to remain firmly linked to the IBDV genome under these conditions. No functional data exist about this circularizing protein; it is a probable candidate for an RNA-dependent RNA polymerase or an assembly protein for the two dsRNA segments. At high particle concentrations, or when the preparations are allowed to stand for several hours before spreading, these complexes tend to aggregate to form flower-like structures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037777     DOI: 10.1016/0042-6822(87)90363-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Infectious Bursal Disease Virus VP3 Upregulates VP1-Mediated RNA-Dependent RNA Replication.

Authors:  Diego Ferrero; Damià Garriga; Aitor Navarro; José F Rodríguez; Núria Verdaguer
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Genome assembly and particle maturation of the birnavirus infectious pancreatic necrosis virus.

Authors:  Rodrigo A Villanueva; José L Galaz; Juan A Valdés; Matilde M Jashés; Ana María Sandino
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  The major antigenic protein of infectious bursal disease virus, VP2, is an apoptotic inducer.

Authors:  A Fernández-Arias; S Martínez; J F Rodríguez
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  The structure of a birnavirus polymerase reveals a distinct active site topology.

Authors:  Junhua Pan; Vikram N Vakharia; Yizhi Jane Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

5.  VP3, a structural protein of infectious pancreatic necrosis virus, interacts with RNA-dependent RNA polymerase VP1 and with double-stranded RNA.

Authors:  Torunn Pedersen; Astrid Skjesol; Jorunn B Jørgensen
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

Review 6.  Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence.

Authors:  M M Nagarajan; F S Kibenge
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

7.  Birnavirus RNA polymerase is related to polymerases of positive strand RNA viruses.

Authors:  A E Gorbalenya; E V Koonin
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

8.  Epigenetic Upregulation of Chicken MicroRNA-16-5p Expression in DF-1 Cells following Infection with Infectious Bursal Disease Virus (IBDV) Enhances IBDV-Induced Apoptosis and Viral Replication.

Authors:  Xueyan Duan; Mingliang Zhao; Yongqiang Wang; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

9.  Sequence conservation in the RNA polymerase gene of infectious bursal disease viruses.

Authors:  F S Kibenge; B Qian
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Identification and molecular characterization of the RNA polymerase-binding motif of infectious bursal disease virus inner capsid protein VP3.

Authors:  Antonio Maraver; Roberto Clemente; Jose Francisco Rodríguez; Eleuterio Lombardo
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.